AKT2 and gastric cancer: In gastric cancer, MiR-29a was revealed to inhibit cell proliferation and induces cell cycle arrest through the downregulation of p42.3, suppress invasion of gastric cancer cells by targeting VEGF-A, AKT2 and Roundabout homolog 1 (Li et al., 2014).